论文信息 - Thalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins? - 字舞流文

Thalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins?

E. Shankar | R. Vignesh

[1] R. Diaz,et al. Thalidomide is Associated With Increased T Cell Activation and Inflammation in Antiretroviral-naive HIV-infected Individuals in a Randomised Clinical Trial of Efficacy and Safety , 2017, EBioMedicine.

[2] T. Kishimoto,et al. A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders. , 2017, Trends in molecular medicine.

[3] Barton F. Haynes,et al. Latency reversal and viral clearance to cure HIV-1 , 2016, Science.

[4] J. Blankson,et al. The Effect of Latency Reversal Agents on Primary CD8 + T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication , 2016, EBioMedicine.

[5] FourcadeCamille,et al. Thalidomide in the Treatment of Immune Reconstitution Inflammatory Syndrome in HIV Patients with Neurological Tuberculosis , 2014 .

[6] J. Lavigne,et al. Thalidomide in the treatment of immune reconstitution inflammatory syndrome in HIV patients with neurological tuberculosis. , 2014, AIDS patient care and STDs.

[7] Fengfei Wang,et al. Thalidomide-a notorious sedative to a wonder anticancer drug. , 2013, Current medicinal chemistry.

[8] S. Doherty,et al. Innovative uses of thalidomide. , 2010, Dermatologic clinics.

[9] V. Werth,et al. Dermatologic therapeutics: thalidomide. A practical guide , 2007, Dermatologic therapy.

[10] S. Tyring,et al. Thalidomide: dermatological indications, mechanisms of action and side‐effects , 2005, The British journal of dermatology.